Pharma Equity Group A/S Cl A (PEG) — Net Asset Momentum
Pharma Equity Group A/S Cl A (PEG) recorded a net asset momentum of -47.9% as of September 2025, with net assets of Dkr25.47 Million DKK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Pharma Equity Group A/S Cl A net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Pharma Equity Group A/S Cl A Net Asset Momentum (2008–2025)
This chart tracks Pharma Equity Group A/S Cl A's year-over-year net asset growth across 18 annual reporting periods from 2008 to 2025. The most recent momentum reading is -47.9%, with net assets of Dkr25.47 Million DKK as of September 2025. For live market cap and overall valuation, see PEG company net worth.
Annual Net Asset History for Pharma Equity Group A/S Cl A (2008–2025)
The table below shows the complete annual net asset history for Pharma Equity Group A/S Cl A from 2008 to 2025, covering 18 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible net worth ratio of Pharma Equity Group A/S Cl A to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (DKK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Dkr25.47 Million | Dkr38.90 Million | Dkr13.43 Million | ▼ -47.9% |
| 2024 | Dkr48.88 Million | Dkr65.61 Million | Dkr16.73 Million | ▲ +92.9% |
| 2023 | Dkr25.33 Million | Dkr67.74 Million | Dkr42.40 Million | ▼ -45.0% |
| 2022 | Dkr46.05 Million | Dkr71.07 Million | Dkr25.03 Million | ▲ +8.2% |
| 2021 | Dkr42.57 Million | Dkr63.65 Million | Dkr21.08 Million | ▲ +24.2% |
| 2020 | Dkr34.28 Million | Dkr57.58 Million | Dkr23.30 Million | ▼ -49.0% |
| 2019 | Dkr67.16 Million | Dkr80.84 Million | Dkr13.68 Million | ▼ -13.4% |
| 2018 | Dkr77.57 Million | Dkr80.84 Million | Dkr3.27 Million | ▼ -8.8% |
| 2017 | Dkr85.09 Million | Dkr86.30 Million | Dkr1.21 Million | ▼ -12.1% |
| 2016 | Dkr96.78 Million | Dkr125.75 Million | Dkr28.98 Million | ▼ -2.8% |
| 2015 | Dkr99.53 Million | Dkr126.25 Million | Dkr26.72 Million | ▲ +1.6% |
| 2014 | Dkr97.95 Million | Dkr123.97 Million | Dkr26.02 Million | ▲ +192.9% |
| 2013 | Dkr-105.44 Million | Dkr251.24 Million | Dkr356.68 Million | ▼ -389.8% |
| 2012 | Dkr36.39 Million | Dkr503.85 Million | Dkr467.46 Million | ▼ -54.3% |
| 2011 | Dkr79.67 Million | Dkr507.76 Million | Dkr428.10 Million | ▲ +50.1% |
| 2010 | Dkr53.06 Million | Dkr497.26 Million | Dkr444.20 Million | ▼ -0.8% |
| 2009 | Dkr53.47 Million | Dkr75.70 Million | Dkr22.24 Million | ▼ -4.9% |
| 2008 | Dkr56.25 Million | Dkr261.67 Million | Dkr205.42 Million | — |